Skip to content

Epilepsy-related Brain Tumors Register

Epilepsy-related Brain Tumors Register

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03876093
Enrollment
0
Registered
2019-03-15
Start date
2018-10-01
Completion date
2024-06-30
Last updated
2021-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

Epilepsy is defined by a cerebral disorder characterized by a lasting predisposition to generate epileptic seizures and by the neurobiological, cognitive, psychological and social consequences of this affection. The definition of epilepsy requires the occurrence of at least one epileptic seizure. 1% of the population suffers from epilepsy. The most common causes are genetic and vascular, 10% of epileptic syndromes are caused by a tumor. The incidence of brain tumors in people with epilepsy is approximately 4%. Among patients with brain tumor (s), the frequency of epilepsy is 30% or more depending on type of tumeur. 30-50% of brain tumors are revealed by an epileptic seizure and 10 to 30% of patients with brain tumor (s) will develop seizures during their evolution. The main objective is to evaluate the frequency of epileptic seizures according to the type of brain tumor.

Interventions

None listed

Sponsors

Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient whose age ≥ 18 years * Patient hospitalized or seen in consultation in the Department of Neurology within the Hospital Group Paris Saint-Joseph * Diagnosis of primary or secondary brain tumor, radiologically and / or histologically * Epilepsy revealing or occurring in a patient developing a brain tumor * Francophone patient

Exclusion criteria

* Pre-existing and known epilepsy before the diagnosis of brain tumors * Epilepsy occurring within 2 weeks postoperatively * Anteriority of taking antiepileptic treatment * Patient under tutorship or curatorship * Patient deprived of liberty * Patient with comprehension disorders making it impossible to understand the protocol * Patient or relative opposing the use of his data

Design outcomes

Primary

MeasureTime frameDescription
number of epileptic seizuresDay 1number of epileptic seizures at the time of neurology consultation or hospitalization

Secondary

MeasureTime frameDescription
number of epileptic seizuresuntil 10 yearsnumber of epileptic seizures at every visit

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026